Trademark: AGENUS 2427860
Word
AGENUS
ID
2427860
Trademark Type
Word
Status
Accepted: In opposition period
Application Date
13 October 2023
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceuticals; therapeutic pharmaceuticals; biologics, namely, biological preparations for medical purposes; monoclonal antibodies for medical purposes; antibodies; adjuvants; vaccines; cell therapy products; cells for medical or clinical use; pharmaceutical preparations and products for the treatment of disease; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease.
Pharmaceuticals; therapeutic pharmaceuticals; biologics, namely, biological preparations for medical purposes; monoclonal antibodies for medical purposes; antibodies; adjuvants; vaccines; cell therapy products; cells for medical or clinical use; pharmaceutical preparations and products for the treatment of disease; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease.